Physician
Neurology
Dr. Victor Biton, MD
|
|
Give Review
Doctor Victor Biton, MD is an expert in the field of Neurology. He graduated from University of Arkansas for Medical Sciences. University of Arkansas for Medical Sciences is ranked 83 in research and 35 in primary care medicine Victor Biton is a published doctor as well. He has 42 publications published. The latest was: Preliminary open-label experience with topiramate in primary generalized seizures. Victor Biton accepts Medicare.
Publications
- Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placeb...
- Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
- Safety and tolerability of different titration rates of retigabine (ezogabine) in patients with partial-onset seizures.
- Long-Term Tolerability and Safety of Lamotrigine Extended-Release: Pooled Analysis of Three Clinical Trials.
- Lacosamide for the treatment of partial-onset seizures.
- A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy.
- Topiramate titration and tolerability.
- Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy.
- Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group.
- Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial.
- Nonfocal generalized tonic-clonic seizures: response during long-term topiramate treatment. Topiramate YTC/YTCE Study Group.
- A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group.
- Preliminary open-label experience with topiramate in primary generalized seizures.
- Multiple sclerosis: genetic versus environmental aetiology: epidemiology in Israel updated.
- Results of temporal lobectomy for the treatment of partial complex epilepsy.
- Central auditory tests and auditory nerve-brainstem evoked responses in multiple sclerosis.
- Prolonged postictal encephalopathy.
- Adjunctive therapy for intractable epilepsy with ethotoin.
- Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures.
- Tolerability and safety of perampanel: two randomized dose-escalation studies.
- Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy.
- Weight change and antiepileptic drugs: health issues and criteria for appropriate selection of an antiepileptic agent.
- Adjunctive lamotrigine XR for primary generalized tonic-clonic seizures in a randomized, placebo-controlled study.
- A randomized, double-blind, placebo-controlled, parallel-group study of rufinamide as adjunctive therapy for refractory partial-onset seizures.
- Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial.
- Gabapentin extended release for the treatment of painful diabetic peripheral neuropathy: efficacy and tolerability in a double-blind, randomized, controlled clinical t...
- Lacosamide for the treatment of diabetic neuropathic pain.
- Long-term oral lacosamide in painful diabetic neuropathy: a two-year open-label extension trial.
- Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures.
- Clinical pharmacology and mechanism of action of zonisamide.
- Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures.
- Bioavailability of a Divalproex Extended-Release Formulation versus the Conventional Divalproex Formulation in Adult Patients Receiving Enzyme-Inducing Antiepileptic D...
- Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study.
- Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy.
- Topiramate in patients with juvenile myoclonic epilepsy.
- Zonisamide: newer antiepileptic agent with multiple mechanisms of action.
- A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
- Divalproex-ER pharmacokinetics in older children and adolescents.
- Levetiracetam and partial seizure subtypes: pooled data from three randomized, placebo-controlled trials.
- Effect of antiepileptic drugs on bodyweight: overview and clinical implications for the treatment of epilepsy.
- Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical...
Procedures Preformed
- EEG (Electroencephalogram)
Doctors Specialties
- Clinical Neurophysiology
- Neurology
Accepted Insurances
Education
-
University of Arkansas for Medical Sciences -
University of Minnesota at Fairview -
The Hebrew University of Jerusalem Hadassah Medical School
Drug Facts
| NPI NUMBER | 1124084124 | |
| NPPES Provider LastName | BITON | |
| NPPES Provider FirstName | VICTOR | |
| NPPES Provider ZIPCode | 722056221 | |
| NPPES Provider State | AR | |
| Specialty Description | Neurology | |
| Total Claim Count | 5138.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1124084124 |
| Last Name Of The Provider | BITON |
| First Name Of The Provider | VICTOR |
| View All |
Similar Doctors
|
|
Dr. Stacy A. Rudnicki, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. May L. Griebel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Z. Chesser, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarkis M. Nazarian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John A. Towbin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Coburn S. Howell Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory B. Sharp, MD |
|
|
Eugene Y. Achi |
|
|
Molly Lim, LCSW |
|
|
Dr. Aimee F. Luat, MD |